• LetThereBeNick@lemmy.zip
      link
      fedilink
      English
      arrow-up
      1
      ·
      3 days ago

      There is good reason to limit off-target drug delivery, to minimize side effects in tissues that don’t need exposure to the drug.

      • Is the oral route more effective than topical?
      • What are the systemic effects of the oral med?
      • Was the study quoted in the article in any way funded by a pharmaceutical company that would be granted an exclusive license for a “new formulation,” or is it trustworthy?
    • Valmond@lemmy.dbzer0.com
      link
      fedilink
      English
      arrow-up
      1
      arrow-down
      4
      ·
      3 days ago

      We actually do not know how medication works.

      You’d be baffled knowing how we research new medications (it’s randomly trying millions of different molecules).

      One breakthrough where we know more is MRNA but that’s just a small part.

      And metabolism? We have a poor understanding of about 10-15%(we don’t even know where it all happens or how much there is), the rest is unknown.

    • patruelis@lemmy.world
      link
      fedilink
      English
      arrow-up
      2
      arrow-down
      4
      ·
      3 days ago

      Do you? We have no idea how much of the medication works. We know it works in some parts better than others through observations and assumptions.

      If we actually knew medicine, we tackle pain, injuries and other ailments through localised medical intervention, not taking a pill and hoping for the best.

      • Arklese1zure@lemmy.zip
        link
        fedilink
        English
        arrow-up
        1
        ·
        2 days ago

        Dude, you’re literally describing pharmacology.

        Localized effects have always been the goal, but actually making a drug that gets only to its intended destination, does a very specific thing, and doesn’t escape to the rest of the body is very hard, very expensive, very painful, or a combination of the three.